Endoscopic ultrasound (EUS) and the management of pancreatic cancer

66Citations
Citations of this article
90Readers
Mendeley users who have this article in their library.

Abstract

Pancreatic cancer is one of the leading causes of cancer-related mortality in western countries. Early diagnosis of pancreatic cancers plays a key role in the management by identification of patients who are surgical candidates. The advancement in the radiological imaging and interventional endoscopy (including endoscopic ultrasound (EUS), endoscopic retrograde cholangiopancreatography and endoscopic enteral stenting techniques) has a significant impact in the diagnostic evaluation, staging and treatment of pancreatic cancer. The multidisciplinary involvement of radiology, gastroenterology, medical oncology and surgical oncology is central to the management of patients with pancreatic cancers. This review aims to highlight the diagnostic and therapeutic role of EUS in the management of patients with pancreatic malignancy, especially pancreatic ductal adenocarcinoma.

Cite

CITATION STYLE

APA

Yousaf, M. N., Chaudhary, F. S., Ehsan, A., Suarez, A. L., Muniraj, T., Jamidar, P., … Farrell, J. J. (2020, May 14). Endoscopic ultrasound (EUS) and the management of pancreatic cancer. BMJ Open Gastroenterology. BMJ Publishing Group. https://doi.org/10.1136/bmjgast-2020-000408

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free